The National Institute on Drug Abuse, founded in 1974, invests in startups in the medical and non-profit sectors, with Peptide Logic being one of its notable portfolio startups. The fund typically invests in deals ranging from $50 to $100 million and participates in 2-6 deals per year. The fund's top activity was in 2019, and it generally invests in rounds with one participant. While startups in this space are often financed by the National Institutes of Health, the National Institute on Drug Abuse plays a significant role.